Qumra Capital

Activity from announced rounds

Activity in this selectionOct 16, 2026 · Jul 19, 2026
Rounds participated in
4
Confirmed lead rounds
0
3 roles undisclosed
New companies
4
First participation on record · 0 follow-on
Funding in participating rounds
$336M
4 disclosed · full round size, not this investor’s share

By stage

Series A1
Series B1
Series C+1
Undisclosed1

By primary sector

Biotech2
Cybersecurity1
Proptech1

By country

Israel3
United States1

Rounds

4 in this selection
Buildots

Construction intelligence software turns site captures into verified progress tracking and early schedule-risk warnings.

$130MFunding
Participant
Remepy

Develops Hybrid Drugs combining prescription medicines with AI-driven therapeutic apps

$36MSeries A
Role not disclosed
QuantHealth

AI-driven platform that simulates clinical trials to predict outcomes before patient enrollment

$45MSeries B
Role not disclosed
Zenity

AI security and governance platform purpose-built for enterprise AI agents

$125MSeries C
Role not disclosed